Red blood cell sodium and potassium after hydrochlorothiazide.
In six of seven healthy males 6 days of hydrochlorothiazide (HCT), 50 mg twice daily, without potassium supplements resulted in a rise in red blood cell (RBC) sodium concentration. Serum potassium concentration fell in all subjects. Four days after discontinuing HCT, intracellular sodium and extracellular potassium concentrations had normalized. Throughout the evaluation period the course of mean relative intracellular sodium was almost a mirror image of mean relative extracellular potassium. Thus, either the decline of serum potassium or of HCT (because of its inhibitory effect on Na-K-ATPase activity) might have diminished Na-K-ATPase-dependent active RBC sodium efflux with a resultant rise in erythrocyte sodium concentration. RBC potassium and serum sodium concentrations were not affected by short-term exposure to HCT.
D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology*; D008297:Male; D011188:Potassium / Q000097:blood* / Q000378:metabolism; D012964:Sodium / Q000097:blood* / Q000378:metabolism; D013997:Time Factors
D006852:Hydrochlorothiazide; D012964:Sodium; D011188:Potassium